showed a trendp = 0.0527
The vasoconstrictor potency was higher in sMAs isolated from hypertensive rats compared to the normotensive group ( Figure 7 B,E), whereas the efficacy showed a trend toward being reduced in SHR ( p = 0.0527) ( Figure 7 C,F).